A Pivotal Study Evaluating Safety and Effectiveness of Adaptative Tip Catheter in Patients With Acute Ischemic Stroke

Recruiting now · Not applicable

Conditions studied: Ischemic Stroke

In brief

The purpose of this study is to assess the safety and the effectiveness of the Adaptive Tip Catheter (ATC) used as a first line direct aspiration thrombectomy technique for patients suffering of an acute ischemic stroke.

Key facts

Study ID

NCT07367100

Run by

Neuravi Limited

People needed

74

Starts

2026-02-02

Expected to finish

2027-07-31

Last updated by the study team

2026-07-31

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age greater than or equal to (>=) 18 years, less than or equal to (<=) 90 years, at the time of consent
• Signs and symptoms consistent with the diagnosis of acute ischemic stroke in the anterior circulation that can be treated with endovascular thrombectomy approaches
• Endovascular treatment can be initiated (defined as access puncture) within 24 hours from time last known well
• Baseline National Institutes of Health Stroke Scale (NIHSS) score >= 6
• Baseline Alberta Stroke Program Early CT Score (ASPECTS) >= 3
• A signed and dated Informed Consent Form (ICF) or Investigator Statement for emergency procedure (as allowed according to country regulations and approved by EC) has been obtained

You may not qualify if…

• Known pregnancy, as evidenced by positive pregnancy test for women of childbearing potential or breast feeding
• Life expectancy less than (<) 90 days prior to stroke onset
• Known hemorrhagic diathesis disorder, coagulation factor deficiency or oral anticoagulant therapy with known International Normalized Ratio (INR) greater than (>) 3.0
• Clinical symptoms and/or CT/MRI evidence suggestive of bilateral stroke or stroke in multiple vascular territories, defined as occlusions in more than one vessel not downstream from each other (for example, bilateral anterior circulation, anterior/posterior circulation)
• Clinical history, past imaging or clinical judgement suggest that the intracranial occlusion is chronic
• Computed Tomography/ Magnetic Resonance Imaging (CT/MRI) evidence of recent/fresh hemorrhage
• Baseline CT or MRI showing mass effect
• Currently participating in an investigational (drug, device, etc.) clinical trial that may confound study endpoints. Patients in observational, natural history, and/or epidemiological studies not involving intervention are eligible
• Cerebral catheter angiographic evidence of pre-existing arterial disease, that potentially impacts treatment and/or outcome (for example, vasculitis)
• Any occlusion or stenosis that limits device access to the target area (for example, carotid dissection, tandem occlusions) or requiring acute stenting to achieve access
• Cerebral catheter angiographic evidence of multiple cerebrovascular occlusions, defined as occlusions in more than one vessel not downstream from each other (for example, bilateral anterior circulation, anterior/posterior circulation)
• Excessive vascular access tortuosity that will likely prevent endovascular access with the adaptive tip catheter (ATC)
• Baseline expanded thrombolysis in cerebral infarction (eTICI) > 1

Where it is running

• UZ Antwerpen — Edegem, Belgium (enrolling)
• Ghent University Hospital — Ghent, Belgium (enrolling)
• Universitair Ziekenhuis Leuven — Leuven, Belgium (enrolling)
• Centre Hospitalier Universitaire de Toulouse - Hopital Purpan — Toulouse, France (enrolling)
• CHRU de Tours — Tours, France (enrolling)
• Universitatsklinikum Schleswig Holstein Kiel — Kiel, Germany (enrolling)
• Universitaetsmedizin Mainz — Mainz, Germany (enrolling)
• Stadtisches Klinikum Solingen gemeinnutzige GmbH — Solingen, Germany (enrolling)
• Universitaetsklinikum Heidelberg — Heidelberg, Germany
• Beaumont Hospital — Dublin, Ireland
• CHU Bordeaux — Bordeaux, France
• CHU Nantes — Nantes, France
• CHU Pitie Salpetriere — Paris, France
• VUMC Amsterdam — Amsterdam, Netherlands
• Maastricht University Medical Centre — Maastricht, Netherlands

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.